Home / Dexamethasone / Italy
IT ATC H02AB02 · updated 2 Nov 2026
Dexamethasone shortage in Italy
Is there a Dexamethasone shortage in Italy?
Yes. As of 2 Nov 2026, 7 Dexamethasone products are reported short in Italy, the first since 1 Apr 2025. The company estimate for the return is 31 Jan 2027. Main reason: commercial decision or withdrawal.
Also short in United States, Canada, Germany, France, Austria, Belgium, Switzerland, Sweden, Australia. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | SOLDESAM | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 1 Apr 2025 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale retail) |
| IT | SOLDESAM | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 1 Oct 2025 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale retail) |
| IT | SOLDESAM | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 4 Dec 2025 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale ospedaliero) |
| IT | SOLDESAM | LABORATORIO FARMACOLOGICO MILANESE S.R.L. | 4 Dec 2025 | not given | Commercial decision or withdrawal Motivi commerciali (carenza relativa solo al canale ospedaliero) |
| IT | DESAMETASONE KALCEKS | AS KALCEKS | 1 Aug 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | DESAMETASONE KALCEKS | AS KALCEKS | 1 Aug 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | DESAMETASONE HAMELN anticipated | HAMELN PHARMA GMBH | 27 Nov 2026 | 31 Jan 2027 | Increased demand Elevata richiesta |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.